GTS Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,200
Closed -$6.93M 3860
2024
Q3
$6.93M Sell
11,200
-14,000
-56% -$8.29M 0.02% 692
2024
Q2
$13.9M Buy
25,200
+4,200
+20% +$2.41M 0.03% 363
2024
Q1
$12.2M Buy
21,000
+900
+4% +$505K 0.02% 429
2023
Q4
$10.7M Sell
20,100
-9,600
-32% -$4.65M 0.02% 578
2023
Q3
$15M Buy
+29,700
New +$15.8M 0.03% 432

Other funds holding TMO

GTS Securities's TMO Position: Q1 2026 in Review

GTS Securities reduced its Thermo Fisher Scientific (TMO) stake by 69% in Q1 2026, selling an estimated $1.43M and leaving 1,198 shares worth $589K. The position accounts for 0.02% of the portfolio, ranked #654.

GTS Securities first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.76M in Q4 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • GTS Securities held 1,198 shares of Thermo Fisher Scientific worth $589K as of Q1 2026.
  • GTS Securities sold 2,633 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.43M.
  • Thermo Fisher Scientific made up 0.02% of GTS Securities's portfolio in Q1 2026, its #654 holding.
  • GTS Securities first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Thermo Fisher Scientific position peaked at $3.76M in Q4 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.